Mitochondria-targeted doxorubicin: A new therapeutic strategy against drug-resistant osteosarcoma. (December 2016) - Buondonno, I.; Gazzano, E.; Sea Rin, J.; Audrito, V.; Kopecka, J.; Fanelli, M.; Salaroglio, I.C.; Costamagna, C.; Roato, I.; Mungo, E.; Hattinger, C.; Deaglio, S.; et al.